PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Jan-2022 Watson-Marlow enhances strong European connections providing further international support for Flexicon Liquid Filling Sciad Newswire
12-Jan-2022 Biotest AG: Biotest AG opens eighth plasma collection centre in Czech Republic Biotest AG
12-Jan-2022 Relief Comments on Lawsuit Filed Against It by NeuroRx RELIEF THERAPEUTICS Holding AG
11-Jan-2022 BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology BRAIN Biotech AG
11-Jan-2022 BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology BRAIN Biotech AG
11-Jan-2022 ProBioGen Announces Innovent as a New Partner Signing License of GlymaxX® Technology B3C newswire
11-Jan-2022 Medios AG: Successful completion of the acquisition of the NewCo Pharma Group - Significant expansion of the market position in the area of manufacturing Medios AG
11-Jan-2022 Evotec expands neuroscience collaboration with Bristol Myers Squibb to include new targeted protein degradation approach Evotec SE
10-Jan-2022 ​​​​​​​Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176 Eckert & Ziegler Strahlen- und Medizintechnik AG
10-Jan-2022 DEFENCE THERAPEUTICS ACHIEVES A MAJOR MILESTONE AND BEGINS IND-ENABLING TESTING OF ITS ACCUTOX LEAD COMPOUND AGAINST BREAST CANCER Defence Therapeutics Inc.
10-Jan-2022 MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference MorphoSys AG
10-Jan-2022 Zur Rose Group nominates Rongrong Hu as director Zur Rose Group AG
10-Jan-2022 Xlife Sciences AG plans listing on the 'Sparks' segment of SIX Swiss Exchange Xlife Sciences AG
09-Jan-2022 Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022 SMi Group
07-Jan-2022 The Transdermal and Microneedle Drug Delivery Virtual Conference 2022 is now only 3 weeks away! SMi Group
07-Jan-2022 F-star Therapeutics to Participate in Upcoming Investor Conferences F-star Therapeutics
07-Jan-2022 NICE Recommends MSD’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy for Routine Commissioning for First-Line Treatment of Adults with Untreated Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)[1] MSD (Merck Sharp & Dohme)
07-Jan-2022 Sosei Heptares and Verily will collaborate to generate novel drug candidates against GPCR targets for immune-mediated diseases Sosei Heptares
07-Jan-2022 Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform Imvaq Therapeutics
07-Jan-2022 Tiziana Life Sciences to Participate in 2022 Biotech Showcase Virtual Investor Conference Tiziana Life Sciences